Myc has been shown to be necessary for cancer progression and maintenance and its upregulation is significantly correlated with aggressive tumor phenotypes and poor clinical outcomes in breast cancer and other neoplasms [1–3, 9–11]. This evidence concerns the gene MYC and neoplasm.